FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3136111932> ?p ?o ?g. }

• W3136111932 endingPage "859" @default.
• W3136111932 startingPage "852" @default.
• W3136111932 abstract "Luteinizing hormone-releasing hormone (LHRH)-agonists in prostate cancer (PCa) patients induce sarcopenic obesity. The effect of LHRH-antagonist on body composition has never been explored. We evaluated changes in fat (FBM) and lean body mass (LBM) in PCa patients undergoing Degarelix. This is a single-center prospective study, enrolling 29 non-metastatic PCa patients eligible to LHRH-antagonist from 2017 to 2019. All patients received monthly subcutaneous injection of Degarelix for 12 months. Changes in FBM and LBM between baseline and 12-month Degarelix, as measured by dual-energy x-ray absorptiometry, were the co-primary endpoints. Secondary endpoints were changes in serum lipids, glucose profile and follicle-stimulating hormone (FSH). Appendicular lean mass index (ALMI) and ALMI/FBM ratio were assessed as post-hoc analyses. Linear mixed models with random intercept tested for estimated least squared means differences (EMD). FBM significantly increased after 12 months (EMD +2920.7, +13.8%, p < 0.001), whereas LBM remained stable (EMD −187.1, −0.3%, p = 0.8). No differences occurred in lipid profile. Glycated hemoglobin significantly increased and serum FSH significantly decreased. A significant inverse relationship was found between serum FSH and ALMI/FBM ratio after 12 month (r = −0.44, p = 0.02). The BLADE study prospectively evaluated changes in body composition after LHRH-antagonist. LHRH-antagonist therapy is associated to an increased risk of obesity and diabetes, but lean body mass and serum lipids are not affected. This may represent an additional evidence supporting the reduced cardiovascular risk associated with LHRH-antagonist. The role of FSH in influencing sarcopenic obesity in PCa after androgen deprivation deserves to be further explored." @default.
• W3136111932 created "2021-03-29" @default.
• W3136111932 creator A5001688100 @default.
• W3136111932 creator A5022883882 @default.
• W3136111932 creator A5026730063 @default.
• W3136111932 creator A5043367155 @default.
• W3136111932 creator A5045260470 @default.
• W3136111932 creator A5049277651 @default.
• W3136111932 creator A5050426287 @default.
• W3136111932 creator A5070395814 @default.
• W3136111932 creator A5070567916 @default.
• W3136111932 creator A5080988702 @default.
• W3136111932 creator A5086741973 @default.
• W3136111932 creator A5091030797 @default.
• W3136111932 creator A5004208730 @default.
• W3136111932 date "2021-03-15" @default.
• W3136111932 modified "2023-09-27" @default.
• W3136111932 title "Changes in body composition and lipid profile in prostate cancer patients without bone metastases given Degarelix treatment: the BLADE prospective cohort study" @default.
• W3136111932 cites W130193209 @default.
• W3136111932 cites W1820440715 @default.
• W3136111932 cites W1978242571 @default.
• W3136111932 cites W1980224053 @default.
• W3136111932 cites W1983380090 @default.
• W3136111932 cites W1999301783 @default.
• W3136111932 cites W2010528776 @default.
• W3136111932 cites W2037412765 @default.
• W3136111932 cites W2044630684 @default.
• W3136111932 cites W2049161486 @default.
• W3136111932 cites W2097930057 @default.
• W3136111932 cites W2131170102 @default.
• W3136111932 cites W2138634479 @default.
• W3136111932 cites W2511755939 @default.
• W3136111932 cites W2511949746 @default.
• W3136111932 cites W2531664284 @default.
• W3136111932 cites W2550252044 @default.
• W3136111932 cites W2801970664 @default.
• W3136111932 cites W2908896518 @default.
• W3136111932 cites W2949925748 @default.
• W3136111932 cites W2989626047 @default.
• W3136111932 cites W2989961673 @default.
• W3136111932 cites W2997721546 @default.
• W3136111932 cites W3011518560 @default.
• W3136111932 cites W3011708870 @default.
• W3136111932 cites W3017175459 @default.
• W3136111932 cites W3027299137 @default.
• W3136111932 cites W3028055237 @default.
• W3136111932 cites W3032046986 @default.
• W3136111932 cites W3036595750 @default.
• W3136111932 cites W3037221203 @default.
• W3136111932 cites W3040044522 @default.
• W3136111932 cites W3085600659 @default.
• W3136111932 doi "https://doi.org/10.1038/s41391-021-00345-0" @default.
• W3136111932 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7958940" @default.
• W3136111932 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33723362" @default.
• W3136111932 hasPublicationYear "2021" @default.
• W3136111932 type Work @default.
• W3136111932 sameAs 3136111932 @default.
• W3136111932 citedByCount "9" @default.
• W3136111932 countsByYear W31361119322021 @default.
• W3136111932 countsByYear W31361119322022 @default.
• W3136111932 countsByYear W31361119322023 @default.
• W3136111932 crossrefType "journal-article" @default.
• W3136111932 hasAuthorship W3136111932A5001688100 @default.
• W3136111932 hasAuthorship W3136111932A5004208730 @default.
• W3136111932 hasAuthorship W3136111932A5022883882 @default.
• W3136111932 hasAuthorship W3136111932A5026730063 @default.
• W3136111932 hasAuthorship W3136111932A5043367155 @default.
• W3136111932 hasAuthorship W3136111932A5045260470 @default.
• W3136111932 hasAuthorship W3136111932A5049277651 @default.
• W3136111932 hasAuthorship W3136111932A5050426287 @default.
• W3136111932 hasAuthorship W3136111932A5070395814 @default.
• W3136111932 hasAuthorship W3136111932A5070567916 @default.
• W3136111932 hasAuthorship W3136111932A5080988702 @default.
• W3136111932 hasAuthorship W3136111932A5086741973 @default.
• W3136111932 hasAuthorship W3136111932A5091030797 @default.
• W3136111932 hasBestOaLocation W31361119321 @default.
• W3136111932 hasConcept C120863210 @default.
• W3136111932 hasConcept C121608353 @default.
• W3136111932 hasConcept C126322002 @default.
• W3136111932 hasConcept C126894567 @default.
• W3136111932 hasConcept C134018914 @default.
• W3136111932 hasConcept C147583825 @default.
• W3136111932 hasConcept C188816634 @default.
• W3136111932 hasConcept C2777180221 @default.
• W3136111932 hasConcept C2777538456 @default.
• W3136111932 hasConcept C2778575703 @default.
• W3136111932 hasConcept C2779279991 @default.
• W3136111932 hasConcept C2780192828 @default.
• W3136111932 hasConcept C2780221984 @default.
• W3136111932 hasConcept C555293320 @default.
• W3136111932 hasConcept C71315377 @default.
• W3136111932 hasConcept C71924100 @default.
• W3136111932 hasConceptScore W3136111932C120863210 @default.
• W3136111932 hasConceptScore W3136111932C121608353 @default.
• W3136111932 hasConceptScore W3136111932C126322002 @default.
• W3136111932 hasConceptScore W3136111932C126894567 @default.
• W3136111932 hasConceptScore W3136111932C134018914 @default.
• W3136111932 hasConceptScore W3136111932C147583825 @default.

• next